Aehr Test Systems [AEHR] vs Lam Research [LRCX] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Aehr Test Systems wins in 5 metrics, Lam Research Corporation wins in 14 metrics, with 0 ties. Lam Research Corporation appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Aehr Test Systems | Lam Research Corporation | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 19.85 | 54.64 | Aehr Test Systems |
| Price-to-Book Ratio | 21.30 | 32.75 | Aehr Test Systems |
| Debt-to-Equity Ratio | 7.22 | 44.20 | Aehr Test Systems |
| PEG Ratio | 0.05 | 1.49 | Aehr Test Systems |
| EV/EBITDA | -249.60 | 43.71 | Lam Research Corporation |
| Profit Margin (TTM) | -25.23% | 30.22% | Lam Research Corporation |
| Operating Margin (TTM) | -41.01% | 33.87% | Lam Research Corporation |
| EBITDA Margin (TTM) | N/A | 33.87% | N/A |
| Return on Equity | -8.68% | 65.57% | Lam Research Corporation |
| Return on Assets (TTM) | -6.10% | 21.05% | Lam Research Corporation |
| Free Cash Flow (TTM) | $-12.39M | $5.41B | Lam Research Corporation |
| Dividend Yield | N/A | 0.55% | N/A |
| 1-Year Return | 858.22% | 309.75% | Aehr Test Systems |
| Price-to-Sales Ratio (TTM) | 66.38 | 16.22 | Lam Research Corporation |
| Enterprise Value | $2.98B | $320.95B | Lam Research Corporation |
| EV/Revenue Ratio | 65.79 | 15.61 | Lam Research Corporation |
| Gross Profit Margin (TTM) | 32.66% | 49.60% | Lam Research Corporation |
| Revenue per Share (TTM) | $2 | $16 | Lam Research Corporation |
| Earnings per Share (Diluted) | $-0.38 | $4.86 | Lam Research Corporation |
| Beta (Stock Volatility) | 2.29 | 1.79 | Lam Research Corporation |
| Short % of Float | 13.96% | 2.50% | Lam Research Corporation |
Aehr Test Systems vs Lam Research Corporation Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Aehr Test Systems | -3.75% | 11.63% | -14.87% | -3.36% | 178.87% | 265.70% |
| Lam Research Corporation | 6.03% | 19.87% | 36.60% | 77.27% | 136.71% | 110.16% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Aehr Test Systems | 858.22% | 175.30% | 4,345.49% | 6,098.29% | 8,577.60% | 1,070.12% |
| Lam Research Corporation | 309.75% | 498.78% | 498.68% | 4,324.73% | 8,551.18% | 8,033.26% |
Performance & Financial Health Analysis: Aehr Test Systems vs Lam Research Corporation
| Metric | AEHR | LRCX |
|---|---|---|
| Market Information | ||
| Market Cap | $3.02B | $324.76B |
| Market Cap Category | Mid cap | Mega cap |
| 10 Day Avg. Volume | 4,133,096 | 8,724,462 |
| 90 Day Avg. Volume | 3,379,249 | 9,726,287 |
| Last Close | $81.04 | $388.92 |
| 52 Week Range | $14.72 - $126.62 | $87.75 - $393.07 |
| % from 52W High | -36.00% | -1.06% |
| All-Time High | $126.62 (Jun 15, 2026) | $393.07 (Jun 15, 2026) |
| % from All-Time High | -36.00% | -1.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.44% | 0.22% |
| Quarterly Earnings Growth | -0.44% | 0.34% |
| Financial Health | ||
| Profit Margin (TTM) | -0.25% | 0.30% |
| Operating Margin (TTM) | -0.41% | 0.34% |
| Return on Equity (TTM) | -0.09% | 0.66% |
| Debt to Equity (MRQ) | 7.22 | 44.20 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $4.48 | $8.11 |
| Cash per Share (MRQ) | $1.17 | $4.95 |
| Operating Cash Flow (TTM) | $-7,444,000 | $7.12B |
| Levered Free Cash Flow (TTM) | $-7,451,625 | $4.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.55% |
| Last 12-Month Dividend | N/A | $1.24 |
Valuation & Enterprise Metrics Analysis: Aehr Test Systems vs Lam Research Corporation
| Metric | AEHR (Apr 26, 2026) | LRCX (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 19.85 | 54.64 |
| Forward P/E | 636.73 | 37.12 |
| PEG Ratio | 0.05 | 1.49 |
| Price to Sales (TTM) | 66.38 | 16.22 |
| Price to Book (MRQ) | 21.30 | 32.75 |
| Market Capitalization | ||
| Market Capitalization | $3.02B | $324.76B |
| Enterprise Value | $2.98B | $320.95B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 65.79 | 15.61 |
| Enterprise to EBITDA | -249.60 | 43.71 |
| Risk & Other Metrics | ||
| Beta | 2.29 | 1.79 |
| Book Value per Share (MRQ) | $4.48 | $8.11 |
Financial Statements Comparison: Aehr Test Systems vs Lam Research Corporation
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | AEHR (2025) | LRCX (2025) |
|---|---|---|
| Revenue/Sales | 58.97M | 18.44B |
| Cost of Goods Sold | 35.04M | 9.46B |
| COGS % of Revenue | 59.4% | 51.3% |
| Gross Profit | 23.93M | 8.98B |
| Gross Margin | 40.6% | 48.7% |
| Research & Development | 10.46M | 2.10B |
| Operating Income (EBIT) | -4.81M | 5.90B |
| Operating Margin | -8.2% | 32.0% |
| EBITDA | -561,000 | 6.55B |
| EBITDA Margin | -1.0% | 35.5% |
| Pre-Tax Income | -4.29M | 5.96B |
| Pre-Tax Income % of Revenue | -7.3% | 32.3% |
| Income Tax | -381,000 | 599.91M |
| Income Tax % of Revenue | -0.6% | 3.3% |
| Net Income (Profit) | -3.91M | 5.36B |
| Profit Margin | -6.6% | 29.1% |
Balance Sheet & Liquidity Metrics
| Metric | AEHR (2025) | LRCX (2025) |
|---|---|---|
| Cash & Equivalents | 24.33M | 6.39B |
| Total Current Assets | 88.78M | 14.52B |
| Total Current Assets % of Revenue | 150.6% | 78.7% |
| Total Current Liabilities | 15.64M | 6.57B |
| Total Current Liabilities % of Revenue | 26.5% | 35.6% |
| Long-Term Debt | 9.92M | 3.73B |
| Long-Term Debt % of Revenue | 16.8% | 20.2% |
| Total Shareholders Equity | 122.87M | 9.86B |
| Retained Earnings | -23.06M | 28.99B |
| Retained Earnings % of Revenue | -39.1% | 157.2% |
| Property, Plant & Equipment | 12.50M | 23.22M |
Cash Flow Statement Comparison
| Metric | AEHR (2025) | LRCX (2025) |
|---|---|---|
| Operating Cash Flow | -2.53M | 6.05B |
| Operating Cash Flow % of Revenue | -4.3% | 32.8% |
| Capital Expenditures | -4.99M | N/A |
| Free Cash Flow | -12.39M | 5.41B |
| FCF Margin | -21.0% | 29.4% |
| Debt Repayment | N/A | -507.49M |
| Common Stock Repurchase | N/A | -3.42B |
Short Interest & Institutional Ownership Analysis
| Metric | AEHR | LRCX |
|---|---|---|
| Shares Short | 4.09M | 27.97M |
| Short Ratio | 2.42 | 2.68 |
| Short % of Float | 13.96% | 2.50% |
| Shares Outstanding | 30.95M | 1.25B |
| Float Shares | 29.55M | 1.24B |
| % Held by Insiders | 4.60% | 0.29% |
| % Held by Institutions | 69.14% | 89.09% |
| % Held by Public | 26.26% | 10.62% |
Dividend Analysis & Yield Comparison: Aehr Test Systems vs Lam Research Corporation
| Metric | AEHR | LRCX |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.24 |
| Last 12-Month Dividend Yield | N/A | 0.55% |
| 3-Year Avg Annual Dividend | N/A | $0.95 |
| 3-Year Avg Dividend Yield | N/A | 0.25% |
| 3-Year Total Dividends | N/A | $2.84 |
| Ex-Dividend Date | N/A | Mar 04, 2026 |